No evidence for GADL1 variation as a bipolar disorder susceptibility factor in a Caucasian lithium-responsive cohort

Am J Psychiatry. 2015 Jan;172(1):94-5. doi: 10.1176/appi.ajp.2014.14070855.
No abstract available

Publication types

  • Letter

MeSH terms

  • Alleles
  • Antimanic Agents / therapeutic use
  • Bipolar Disorder / drug therapy
  • Bipolar Disorder / genetics*
  • Carboxy-Lyases / genetics*
  • European Continental Ancestry Group
  • Genetic Predisposition to Disease*
  • Humans
  • Lithium / therapeutic use

Substances

  • Antimanic Agents
  • Lithium
  • Carboxy-Lyases
  • GADL1 protein, human